Company Directory / biotechnology
PrivateFor profitbiotechnologyMilton, United Kingdom
Chroma Medicine
Chroma Medicine is a new genomic medicine company working on epigenetic editing.
- Founded
- 2021 5 years ago
- Staff
- 101-250 band, as listed
- Followers
- - on LinkedIn
- Funding
- $260M as listed, currency not stated
Set against six million companies
Size
101-250 people: larger than 85% of companies with a size listed
Age
5 years old.
Reach
Website ranked #3,055,088 in the world for traffic, about 5k visits a month.
What it does
BiotechnologyMedicalTherapeutics
Funding, as listed
$260M currency not stated
- Rounds3
- LatestSeries b, Mar 2023
- Investors16, 4 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Chroma Medicine, field by field. Contact details are held but never shown.
The company
- Name
- Chroma Medicine
- Type
- For profit
- Status
- Private
- Founded
- 2021
- Founders
- Angelo Lombardo, David R. Liu, J. Keith Joung, Jonathan Weissman, Luigi Naldini, Luke Gilbert
- Industry
- biotechnology
- Categories
- Biotechnology, Medical, Therapeutics
Where
- City
- Milton
- Country
- United Kingdom
- Markets
- Greater Boston Area, East Coast, New England, Northeastern US
Size and reach
- Staff band
- 101-250
- Web traffic rank
- #3,055,088
- Monthly web visits
- 5,114
Funding, as listed
- Total
- 260,000,000 (currency not stated)
- Rounds
- 3
- Latest round
- Series b
- Latest round date
- Mar 2023
- Investors
- 16
- Lead investors
- 4
- Listing status
- private
Corporate family
- Acquisitions made
- 1
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Chroma Medicine may be growing as indicated by a study they sponsored showing long-term epigenetic silencing in mice, which supports the therapeutic use of their epigenetic editing approach. This research could potentially contribute to the company's credibility and future revenue streams in the biotechnology industry. Furthermore, the overall epigenetics market, which is relevant to Chroma Medicine's field of operation, is forecasted to grow significantly, reaching over USD 61.04 billion by 2033, suggesting a favorable market environment for the company's growth.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
biotechnology in United Kingdom.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 372,993 companies in United Kingdom and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.